Clinical Trial Update: An Exploratory Study on the Failure of Immunotherapy With Voronib Combined With Everolimus [Phase 2]

View source ↗

Summary

This entry notes a Phase 2 exploratory trial of Voronib in combination with Everolimus for renal cell carcinoma. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Everolimus (everolimus)
• Voronib

Snippet

Sponsor: Sun Yat-sen University | Conditions: Renal Cell Carcinoma Stage I | Phase 2 | Status: RECRUITING